Moreover, in metastatic prostate cancer, PDGF-D was reported to be a regulator of osteoclastic differentiation that is critical for the establishment of skeletal metastatic deposits in prostate cancer patients72. This evidence concerns the gene PDGFD and metastatic prostate carcinoma.